39. Hasselberg, N. E. Lamin A/C cardiomyopathy: young onset, high penetrance, and frequent need for heart transplantation / N. E. Hasselberg, T. F. Haland, J. Saberniak et al. // Eur Heart J. – 2018. – № 39. – Р. 853–860.
40. Heidbuchel, H. Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: results from the cohort / H. Heidbuchel, R. Willems, L. Jordaens et al. // Eur J Prev Cardiol. – 2019. – № 26. – P. 764–775.
41. Hsu, J. J. Monomorphic Ventricular Arrhythmias in Athletes / J. J. Hsu, A. Nsair, J. A Aboulhosn, T. B. Horwich et al. // Arrhythm Electrophysiol Rev. – 2019. – V. 8. – № 2. – P. 83–89.
42. Iskandar, A. Diseases of the Aorta in Elite Athletes / A. Iskandar, P. D. Thompson // Clin Sports Med. – 2015. – V. 34. – № 3. – P. 461–472.
43. Kikuchi, N. Long-Term Prognostic Role of the Diagnostic Criteria for Arrhythmogenic Right Ventricular Cardiomyopathy / N. Kikuchi, D. Yumino, T. Shiga, A. Suzuki, N. Hagiwara // Dysplasia. JACC Clin. Electrophysiol. – 2016. – № 2. – P. 107–115.
44. Kochi, A. N. Farzam, Sudden Cardiac Death in Athletes: From the Basics to the Practical Work-Up / A. N. Kochi, G. Vettor // Medicina (Kaunas). – 2021. – V. 2. – № 57. – P. 168.
45. Lampert, R. Updated Recommendations for Athletes with Heart Disease / R. Lampert, D. P. Zipes // Annu Rev Med. – 2018. – № 69. – P. 177–189.
46. Lampеrt, R. Safety of sports for athletes with implantable cardioverter-defibrillators: results of a prospective, multinational registry / R. Lampert, B. Olshansky, H. Heidbuchel, et al. // Circulation. – 2013. – № 127. – P. 2021–2030.
47. Levine, B. D. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 1: Classification of sports: dynamic, static, and impact: a scientific statement from the American Heart Association and American College of Cardiology / B. D. Levine, A. L. Baggish, R. J. Kovacs et al. // J Am Coll Cardiol. – 2015. – № 66. – P. 2350–2355.
48. Lorenzini, M. Mortality among Referral Patients with Hypertrophic Cardiomyopathy vs the General European Populationv / M. Lorenzini, Z. Anastasiou, C. O’Mahony et al. // JAMA Cardiol. – 2020. – № 5. – V. 73–80.
49. MacLachlan, H. Cardiac evaluation of young athletes: Time for a risk-based approach? / H. MacLachlan, J. A. Drezner // Clin Cardiol. – 2020. – V. 8. – № 43. – P. 906–914.
50. Malhotra, A. Outcomes of cardiac screening in adolescent soccer players / A. Malhotra, H. Dhutia, G. Finocchiaro et al. // N Engl J Med. – 2018. – V. 379. – № 6. – P. 524–534.
51. Maron, B. J. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Preamble, Principles, and General Considerations / B. J. Maron, D. P. Zipes // J Am Coll Cardiol. – 2015. – V. 66. – № 21. – P. 2343–2349.
52. Maron, B. J. On behalf of the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Functional Genomics and Translational Biology, and the American College of Cardiology. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 3: Hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American Heart Association and American College of Cardiology / B. J. Maron, J. E. Udelson, R. O. Bonow // J Am Coll Cardiol. – 2015. – № 66. – P. 2362–2371.
53. Mavrogeni, S. I. Sudden cardiac death in athletes and the value of cardiovascular magnetic resonance / S. I. Mavrogeni, F. Bacopoulou, D. Apostolaki, G. P. Chrousos // Eur J Clin Invest. – 2018. – V. 48. – № 7.
54. Meyer, L. Incidence, causes, and survival trends from cardiovascular-related sudden cardiac arrest in children and young adults 0 to 35 years of age: a 30-year review / L. Meyer, B. Stubbs, C. Fahrenbruch et al. // Circulation. – 2012. – № 126. – P. 1363–1372.
55. Morseth, B. Physical activity, resting heart rate, and atrial fibrillation: the Tromso Study Graff-Iversen S. / B. Morseth, B. K. Jacobsen // Eur Heart J. – 2016. – № 37. – Р. 2307–2313.
56. Nalliah, C. J. Mitral valve prolapse and sudden cardiac death: a systematic review and meta-analysis / C. J. Nalliah, R. Mahajan, A. D. Elliott et al. // Heart. – 2019. – V. 105. – № 2. – P. 144–151.
57. Novak, J. Electrocardiographic differentiation of idiopathic right ventricular outflow tract ectopy from early arrhythmogenic right ventricular cardiomyopathy / J. Novak, A. Zorzi, S. Castelletti et al. // Europace. – 2017. – № 19. – P. 622–8.
58. Olshansky, B. Competitive athletes with implantable cardioverter-defibrillators – how to program? Data from the Implantable Cardioverter-Defibrillator Sports Registry / B. Olshansky, G. Atteya, D. Cannom et al. // Heart Rhythm. – 2019. – № 16. – P. 581–587.
59. Papagiannis, J. Sudden death due to aortic pathology / J. Papagiannis // Cardiol Young. – 2017. – V. 27. – № 1. – P. 36–42.
60. Pelliccia, A. ESC Scientific Document Group. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease / A. Pelliccia, S. Sharma, S. Gati, M. Bäck, M. Börjesson, Caselli et al. // Eur Heart J. – 2021. – V. 42. – P. 17–96.
61. Pelliccia, A. European Association of Preventive Cardiology (EAPC) and European Association of Cardiovascular Imaging (EACVI) joint position statement: recommendations for the indication and interpretation of cardiovascular imaging in the evaluation of the athlete's heart / A. Pelliccia et al. // Eur Heart J. – 2018. – V. 39. – № 21. – P. 1949–1969.
62. Priori, S. G. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) / S. G. Priori, C. Blomstrom-Lundqvist, A. Mazzanti et al. // Евро. Heart J. – 2015. – № 36. – P. 2793–2867.
63. Rabanal-Ruiz, Y. The Use of Coenzyme Q10 in Cardiovascular Diseases / Y. Rabanal-Ruiz, E. Llanos-González, F. J. Alcain // Antioxidants (Basel). – 2021. – V. 5. – № 10. – P. 755.
64. Rizzo, S. Sudden Death and Coronary Artery Anomalies / S. Rizzo, M. De Gaspari, C. Frescura. – 2021. – № 8.
65. Rusinaru, D. Left Atrial Volume and Mortality in Patients With Aortic Stenosis / D. Rusinaru, Y. Bohbot, C. Kowalskiet al. // J Am Heart Assoc. – 2017. – V. 6. – № 11.
